Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA.

Marouf A,Chaubard S,Liévin R,Michot J,Molinari N,Rossignol J,Cavalieri D,Golfier C,Allangba O,Philippe L,Tessoulin B,Chauchet A,Deau B,Oberic L,Vargaftig J,Moignet A,Clavert A,Dulery R,Brisou G,Tardy S,Fataccioli V,Houot R,Casasnovas R,Thieblemont C,Ghesquières H,Carras S,Le Gouill S,Cartron G,Ribrag V,Cheminant M,Marçais A,Suarez F,Marabelle A,Tournilhac O,Damaj G,Gaulard P,De Leval L,Lemonnier F,Bachy E,Chevret S,Hermine O,Couronné L,Jaccard A

Source :

Hemasphere

2025 Jan 20

Pmid / DOI:

39840381